Tectonic Therapeutic | AVRO - Current Assets



Tectonic Therapeutic reported $290.85M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Adcock Ingram Holdings ZAR 5.12B 234.71M Dec/2024
Alnylam Pharmaceuticals USD 3.64B 375.44M Jun/2025
Celltrion KRW 5.46T 122.95B Mar/2025
Cspc Pharmaceutical CNY 21.89B 4.58B Dec/2024
Dianthus Therapeutics USD 263.6M 17.3M Jun/2025
Divis Laboratories Ltd 100.81B 7.4B Mar/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
Kangmei Pharma CNY 6.9B 6.92M Jun/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 516.3M 26.69M Jun/2025
MacroGenics USD 204.94M 12.55M Jun/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.41M 7.26M Dec/2024
Neuren Pharmaceuticals AUD 399.33M 171.29M Dec/2024
Organigram Holdings CAD 277.78M 46.29M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Pharma Mar EUR 249.4M 13.39M Jun/2025
Qiagen NV USD 1.82B 76.12M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
Sarepta Therapeutics USD 2.66B 224.45M Jun/2025
Sartorius EUR 2.17B 7.5M Jun/2025
Sino Biopharmaceutical CNY 24.69B 536.66M Dec/2024
Takeda JPY 2.51T 8.07B Jun/2025
Tilray USD 707.34M 18.54M Nov/2024
Zz Pientze Pharmaceu 12.29B 113.34M Jun/2025